Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS at Tikur Anbessa Specialized Hospital, Ethiopia

Ruth Demessie, Alemayehu Mekonnen, Wondwossen Amogne, Workineh Shibeshi

Abstract


Background: Adherence to antiretroviral therapy (ART) is necessary to achieve best virological response, lower the risk of drug resistance, and reduce morbidity and mortality. The objectives of the current study were to assess the extent of knowledge of patients on treatment plan and regimen, determine the rate of adherence and identify factors related to non-adherence to ART.

Methods: A cross-sectional study was conducted at Tikur Anbessa Specialized Teaching Hospital, Addis Ababa, Ethiopia, using data from both semi-structured interview (self-report) and ART database (pharmacy refill) during the months of March and April 2013 using a total 350 participants.

Results: The results indicated that 33% of the participants had good knowledge on the treatment plan and regimen. Using self-report and pharmacy refill record, 79.1% and 72.9% respectively showed adherence rate of ≥95%. Younger people were found to be less likely to adhere to ART (AOR [95%] = 0.51 [0.30, 0.85]) using pharmacy refill record. Risk factors for ART non-adherence using self-report were use of memory aids (AOR [95%] = 3.46 [1.72, 6.98]), treatment satisfaction (AOR [95%] = 2.33 [1.22, 4.07]), taking co-medication (AOR [95%] = 0.56 [0.32, 0.98]), and regimen switch (AOR [95%] = 0.41 [0.19, 0.85]). Whereas using pharmacy refill record risk factors were, knowledge on treatment plan and regimen (AOR [95%] = 2.50 [1.39, 4.51]), use of memory aids (AOR [95%] = 2.71 [1.34, 5.47]), treatment satisfaction (AOR [95%] = 3.78 [1.47, 9.71]), and regimen switch (AOR [95%] = 0.50 [0.27, 0.92]).

Conclusion: Older age, good knowledge on treatment plan and regimen, use of memory aids, treatment satisfaction, and not having co-medications and regimen switch showed more adherence to ART.


Keywords


Adherence, Non-adherence, Antiretroviral drugs, Antiretroviral therapy, HIV/AIDS

Full Text:

PDF

References


Monjok E, Smesny A, Okokon BI, Mgbere O, Essien JE. Adherence to antiretroviral therapy in Nigeria: an overview of research studies and implications for policy and practice. HIV/AIDS - Res Palliat Care. 2010;2:69-76.

World Health Organization (WHO). Antiretroviral therapy. 2011. Available from: http://www.who.int/hiv/topics/treatment/art/en/index.html. [Last accessed on 2013 Mar 03].

World Health Organization (WHO). The strategic use of antiretroviral to help end the HIV epidemic. 2012. Available from: http://www.who.int. [Last accessed on 2013 Mar 03].

Amberbir A, Woldemichael K, Getachew S, Girma B, Deribe K. Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia. BMC Cent Public Health. 2008;8:265. [DOI via Crossref]

Lazo M, Gange SJ, Wilson TE, Anastos K, Ostrow DG, Witt MD, et al. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. Clin Infect Dis. 2007;45:1377-85. [DOI via Crossref]

Murphy DA, Marelich WD, Rappaport NB, Hoffman D, Farthing C. Results of an antiretroviral adherence intervention: STAR (staying healthy: taking antiretrovirals regularly). J Int Assoc Physicians AIDS Care. 2007;6(2):113-24. [DOI via Crossref]

Li L, Lee SJ, Wen Y, Lin C, Wan D, Jiraphongsa C. Antiretroviral therapy adherence among patients living with HIV/AIDS in Thailand. Nurs Health Sci. 2010;12(2):212-20. [DOI via Crossref]

Gulick RM. Adherence to antiretroviral therapy: how much is enough? Clin Infect Dis. 2006;43:942-4. [DOI via Crossref]

Unge C, So dergard B, Marrone G, Thorson A, Lukhwaro A, Carter J, et al. Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in Sub-saharan Africa: a prospective cohort study. PLoS ONE. 2010;5:10. [DOI via Crossref]

Chee-Jen C, Ross-Degnan D, Pierre-Jacques M, Zhang F, Tadeg H, Gitau L, et al. Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators. BMC Health Serv Res. 2010;10:42. [DOI via Crossref]

Jones DL, Baker Shvawn Mc P, Lydston D, Camille J, Brondolo E, Tobin JN, et al. Efficacy of a group medication adherence intervention among HIV positive women: the SMART/EST women's project. Natl Inst Health: AIDS Behav. 2007;11(1):79-86.

Scanlon ML, Vreeman RC. Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV/AIDS - Res Palliat Care. 2013;5:1-17. [DOI via Crossref]

Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in Sub-Saharan Africa and North America. J Am Med Assoc. 2006;296:679-90. [DOI via Crossref]

Mengesha A, Worku A. Assessment of antiretroviral treatment among HIV infected persons in the Ministry of Defense Hospitals. AAU, MPH Thesis; 2005.

Potchoo Y, Tchamdja K, Balogou A, Pitche VP, Guissou IP, Kassang EK. Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centers of the association "Espoir Vie Togo" in Togo, West Africa. Journal o BMCl Pharmacology 2010, 10:11.

Reda AA, Biadgilign S. Determinants of adherence to antiretroviral therapy among HIV-infected patients in Africa. AIDS Res Treat. 2012;2012:574656.

Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34:281-8. [DOI via Crossref]

Lyimo RA, Bruin M, Boogaard J, Hospers HJ, Ven A, Mushi D. Determinants of antiretroviral therapy adherence in northern Tanzania: a comprehensive picture from the patient perspective. BMC Cent Public Health. 2012;12:716. [DOI via Crossref]

Potchoo Y, Tchamdja K, Balogou A, Pitche VP, Guissou IP, Kassang EK. Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centers of the association "Espoir Vie Togo" in Togo, West Africa. BMC Clin Pharmacol. 2010;10:11. [DOI via Crossref]

FMOH. Health and Health Related Indicators, Planning and programming Department. Addis Ababa: FMOH; 2007.

Drug and Therapeutics Committee of Tikur Anbessa General Specialized Hospital in collaboration with PFSA and MSH/SIAPS. List of pharmaceuticals for Tikur Anbessa specialized hospital. 1st Edition. 2012. Addis Ababa, Ethiopia.

Ekama SO, Herbertson EC, Addeh EJ, Okafor CVG, Onwujekwe DI, Tayo F, et al. Pattern and determinants of antiretroviral drug adherence among Nigerian pregnant women. J Pregnancy. 2012;2012:851810. [DOI via Crossref]

Li L, Lee SJ, Thammawijayab P, Jiraphongsab C, Jane M, Borusa R. Stigma, social support, and depression among people living with HIV in Thailand. Natl Inst Health-AIDS Care. 2009;21(8);1007-13. [DOI via Crossref]

Markos E, Worku A, Davey G: Adherence to ART in PLWHA at Yirgalem Hospital, South Ethiopia. Ethiopian Journal of Health Development 2008;22(2):174-179.

Chalker JC, Andualem T, Gitau LN, Ntaganira J, Obua C, Tadeg, H et al. Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators. BMC Health Serv Res. 2010;10:43. [DOI via Crossref]

Wasti SP, Simkhada P, Randall J, Freeman JV, van Teijlingen E. Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. PLoS ONE. 2012;7:5. [DOI via Crossref]

Bonolo PF, César CC, Acurcio FA, et al: Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil. AIDS 2005;19 (suppl 4):s5-s13. [DOI via Crossref]

Etard JF, Lanièce I, Fall MB, Cilote V, Blazejewski L, Diop K, Desclaux A, Ecochard R, Ndoye I, Delaporte E. A 84-month follow up of adherence to HAART in a cohort of adult Senegalese patients. Trop Med Int Health. 2007;12(10):1191-8. [DOI via Crossref]

Laniece I, Desclaux A, Ciss M, Diop K, Ndiaye B. Adherence to HAART and its principal determinants in a cohort of Senegalese adults. In: Desclaux A, Laniece I, Ndoye I, editors. Paris: ANRS; 2002: 97-108.

Kleebergera CA, Buechnera J, PalellabFra, Detelsc R, Riddlerd S, Godfreya R, et al. Changes in adherence to highly active antiretroviral therapy medications in the multicenter AIDS Cohort Study. AIDS. 2004;18:683-8. [DOI via Crossref]

Orrell C, Bangsberg DR, Badri M, Wood R. Adherence is not a barrier to successful antiretroviral therapy in South Africa. J Acquir Immune Defic Syndr. 2003;17:1369-75.

Charurat M, Oyegunle M, Benjamin R, Habib A, Eze E, Ele P, et al. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PLoS ONE. 2010;5(5):e10584. [DOI via Crossref]

Lyimo RA, Bruin M, Boogaard J, Hospers HJ, Ven A, Mushi D. Determinants of antiretroviral therapy adherence in northern Tanzania: a comprehensive picture from the patient perspective. J Bio Med Cent Public Health. 2012;12:716. [DOI via Crossref]

American Public Health Association, 2004. Adherence to HIV treatment regimens: recommendations for best practices. Available from: http://www.apha.org/ppp/hiv.

Wakibi SN, W Ng'ang'a Z, Mbugua GG. Factors associated with non-adherence to highly active antiretroviral therapy in Nairobi, Kenya. AIDS Res Ther. 2011;8:43. [DOI via Crossref]